367 related articles for article (PubMed ID: 22671971)
1. Efficacy and safety of 'true' cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: a systematic review and meta-analysis.
Ranasinghe P; Jayawardana R; Galappaththy P; Constantine GR; de Vas Gunawardana N; Katulanda P
Diabet Med; 2012 Dec; 29(12):1480-92. PubMed ID: 22671971
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of 'true' cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: a systematic review and meta-analysis.
Akilen R; Tsiami A; Robinson N
Diabet Med; 2013 Apr; 30(4):505-6. PubMed ID: 23157193
[No Abstract] [Full Text] [Related]
3. Response to Akilen et al. Efficacy and safety of 'true' cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: a systematic review and meta-analysis.
Ranasinghe P; Jayawardena R; Galappaththy P; Constantine GR; de Vas Gunawardana N; Katulanda P
Diabet Med; 2013 Apr; 30(4):506-7. PubMed ID: 23350728
[No Abstract] [Full Text] [Related]
4. Cinnamomum zeylanicum (Ceylon cinnamon) as a potential pharmaceutical agent for type-2 diabetes mellitus: study protocol for a randomized controlled trial.
Ranasinghe P; Galappaththy P; Constantine GR; Jayawardena R; Weeratunga HD; Premakumara S; Katulanda P
Trials; 2017 Sep; 18(1):446. PubMed ID: 28962661
[TBL] [Abstract][Full Text] [Related]
5. To what extent does cinnamon administration improve the glycemic and lipid profiles?
Santos HO; da Silva GAR
Clin Nutr ESPEN; 2018 Oct; 27():1-9. PubMed ID: 30144878
[TBL] [Abstract][Full Text] [Related]
6. The potential of cinnamon to reduce blood glucose levels in patients with type 2 diabetes and insulin resistance.
Kirkham S; Akilen R; Sharma S; Tsiami A
Diabetes Obes Metab; 2009 Dec; 11(12):1100-13. PubMed ID: 19930003
[TBL] [Abstract][Full Text] [Related]
7. Antidiabetic effect of Cinnamomum cassia and Cinnamomum zeylanicum in vivo and in vitro.
Verspohl EJ; Bauer K; Neddermann E
Phytother Res; 2005 Mar; 19(3):203-6. PubMed ID: 15934022
[TBL] [Abstract][Full Text] [Related]
8. Medicinal properties of 'true' cinnamon (Cinnamomum zeylanicum): a systematic review.
Ranasinghe P; Pigera S; Premakumara GA; Galappaththy P; Constantine GR; Katulanda P
BMC Complement Altern Med; 2013 Oct; 13():275. PubMed ID: 24148965
[TBL] [Abstract][Full Text] [Related]
9. Do Cinnamon Supplements Have a Role in Glycemic Control in Type 2 Diabetes? A Narrative Review.
Costello RB; Dwyer JT; Saldanha L; Bailey RL; Merkel J; Wambogo E
J Acad Nutr Diet; 2016 Nov; 116(11):1794-1802. PubMed ID: 27618575
[TBL] [Abstract][Full Text] [Related]
10. Cinnamon for diabetes mellitus.
Leach MJ; Kumar S
Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD007170. PubMed ID: 22972104
[TBL] [Abstract][Full Text] [Related]
11. Cinnamaldehyde--a potential antidiabetic agent.
Subash Babu P; Prabuseenivasan S; Ignacimuthu S
Phytomedicine; 2007 Jan; 14(1):15-22. PubMed ID: 17140783
[TBL] [Abstract][Full Text] [Related]
12. Verification of the antidiabetic effects of cinnamon (Cinnamomum zeylanicum) using insulin-uncontrolled type 1 diabetic rats and cultured adipocytes.
Shen Y; Fukushima M; Ito Y; Muraki E; Hosono T; Seki T; Ariga T
Biosci Biotechnol Biochem; 2010; 74(12):2418-25. PubMed ID: 21150113
[TBL] [Abstract][Full Text] [Related]
13. Effects of the polyphenol content on the anti-diabetic activity of Cinnamomum zeylanicum extracts.
IM K; Issac A; NM J; Ninan E; Maliakel B; Kuttan R
Food Funct; 2014 Sep; 5(9):2208-20. PubMed ID: 25051315
[TBL] [Abstract][Full Text] [Related]
14. Homalium zeylanicum attenuates streptozotocin-induced hyperglycemia and cellular stress in experimental rats via attenuation of oxidative stress imparts inflammation.
Rout D; Dash UC; Kanhar S; Swain SK; Sahoo AK
J Ethnopharmacol; 2022 Jan; 283():114649. PubMed ID: 34536517
[TBL] [Abstract][Full Text] [Related]
15. The Anti-Diabetic Effect of Some Plant Extracts Against Streptozotocin - Induced Diabetes Type 2 in Male Albino Rats.
Gomaa HF; Abdelmalek IB; Abdel-Wahhab KG
Endocr Metab Immune Disord Drug Targets; 2021; 21(8):1431-1440. PubMed ID: 33069202
[TBL] [Abstract][Full Text] [Related]
16. Cinnamon in glycaemic control: Systematic review and meta analysis.
Akilen R; Tsiami A; Devendra D; Robinson N
Clin Nutr; 2012 Oct; 31(5):609-15. PubMed ID: 22579946
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of cinnamon in patients with type II diabetes mellitus: A randomized controlled clinical trial.
Zare R; Nadjarzadeh A; Zarshenas MM; Shams M; Heydari M
Clin Nutr; 2019 Apr; 38(2):549-556. PubMed ID: 29605574
[TBL] [Abstract][Full Text] [Related]
18. Meliacinolin: a potent α-glucosidase and α-amylase inhibitor isolated from Azadirachta indica leaves and in vivo antidiabetic property in streptozotocin-nicotinamide-induced type 2 diabetes in mice.
Perez-Gutierrez RM; Damian-Guzman M
Biol Pharm Bull; 2012; 35(9):1516-24. PubMed ID: 22975503
[TBL] [Abstract][Full Text] [Related]
19. Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis.
Allen RW; Schwartzman E; Baker WL; Coleman CI; Phung OJ
Ann Fam Med; 2013; 11(5):452-9. PubMed ID: 24019277
[TBL] [Abstract][Full Text] [Related]
20. Cinnamon as a Complementary Therapeutic Approach for Dysglycemia and Dyslipidemia Control in Type 2 Diabetes Mellitus and Its Molecular Mechanism of Action: A Review.
Silva ML; Bernardo MA; Singh J; de Mesquita MF
Nutrients; 2022 Jul; 14(13):. PubMed ID: 35807953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
